Inhaled nitric oxide in patients with severe heart failure: changes in lung perfusion and ventilation detected using scintigraphy

Thorac Cardiovasc Surg. 1996 Feb;44(1):35-9. doi: 10.1055/s-2007-1011980.

Abstract

Inhaled nitric oxide (NO) is a selective pulmonary vasodilator in patients with end-stage cardiac failure. Preoperative high pulmonary vascular resistance could modify early and late results after heart transplantation generally due to right-ventricular failure. Aim of this study was to assess pulmonary vascular resistance variability following inhalation of NO by using a scintigraphic method. Our preliminary results suggest that inhaled NO in patients with end-stage heart failure redistributes blood away from apical regions and towards more basal and posterior segments, probably dilating blood vessels in ventilated but nonperfused zones. NO may represent a simple and reliable method to evaluate dynamic response of pulmonary vasculature.

MeSH terms

  • Administration, Inhalation
  • Adult
  • Aged
  • Dose-Response Relationship, Drug
  • Female
  • Heart Failure / physiopathology
  • Heart Failure / surgery*
  • Heart Transplantation*
  • Humans
  • Hypertension, Pulmonary / drug therapy
  • Hypertension, Pulmonary / physiopathology
  • Lung / blood supply
  • Lung / diagnostic imaging*
  • Male
  • Middle Aged
  • Nitric Oxide / administration & dosage
  • Nitric Oxide / therapeutic use*
  • Pulmonary Circulation*
  • Radionuclide Imaging
  • Vascular Resistance / drug effects
  • Ventilation-Perfusion Ratio / drug effects*

Substances

  • Nitric Oxide